» Articles » PMID: 28404514

Postpartum Glucose Testing, Related Factors and Progression to Abnormal Glucose Tolerance in a Rural Population with a Known History of Gestational Diabetes

Overview
Specialty Endocrinology
Date 2017 Apr 14
PMID 28404514
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Gestational diabetes is a strong risk factor for postpartum progression to glucose intolerance. The aims of the study were to determine rate of postpartum glucose testing , its related factors and rate of progression to glucose intolerance in women who underwent postpartum glucose testing after pregnancy that complicated by gestational diabetes.

Materials: this is a retrospective study and women with gestational diabetes who received prenatal care during 2005-2015 in 3 rural health centers of Khuramshahr (southwestern of Iran) were enrolled. Gestational diabetes mellitus diagnosed by FPG test only, 75g OGTT or GCT. The American Diabetes Association(ADA) criteria applied for definition of postpartum glucose intolerance (pre-diabetes or diabetes) .

Results: Mean duration of follow-up was 29.7 months. BMI≥ 25 was detected in 73.3% and 78.7% of women during pre-pregnancy and postpartum respectively. Overall 45.8% (60/131) of women received postpartum glucose testing. Rate of progression to abnormal glucose tolerance was 23.3% (8.5% pre-diabetes and 15.2% diabetes). Advanced maternal age was associated with postpartum glucose testing (OR 1.066, CI 1.008-1.128, p=0.02).

Discussion: high rate of overweight and obesity, sub optimal rate of postpartum glucose testing and high prevalence of glucose intolerance, highlights the importance of postpartum screening with a more sensitive test and implementation of an intervention program to prevent type 2 diabetes in rural population particularly older women with prior gestational diabetes.

Citing Articles

Fasting glucose levels at diagnosis and delivery are associated with postpartum glucose abnormalities in GDM women.

Gu Y, Chen Y, Hu L, Chen S, Wang L, Chen M Arch Gynecol Obstet. 2025; .

PMID: 39873768 DOI: 10.1007/s00404-025-07953-4.


Comparison of the Onset and End of Specific and Major Side Effects in Iranian Teenage Participants Vaccinated With COVID-19 Vaccine: Sinopharm and Soberana.

Tavakoli N, Nafissi N, Shokri S, Fallahpour M, Soleimani S, Riahi T Med J Islam Repub Iran. 2023; 37:15.

PMID: 37123336 PMC: 10134091. DOI: 10.47176/mjiri.37.15.


Prevalence of prediabetes and type 2 diabetes mellitus in south and southeast Asian women with history of gestational diabetes mellitus: Systematic review and meta-analysis.

Shivashri C, Hannah W, Deepa M, Ghebremichael-Weldeselassie Y, Anjana R, Uma R PLoS One. 2022; 17(12):e0278919.

PMID: 36508451 PMC: 9744276. DOI: 10.1371/journal.pone.0278919.


Effectiveness of Mobile Call Reminders and Health Information Booklet to Improve Postnatal Blood Glucose Monitoring among Mothers with Gestational Diabetes Mellitus Receiving Care from a Tertiary Health Centre, Puducherry - A Randomized Controlled....

Manoharan N, Jayaseelan V, Kar S, Jha N Indian J Endocrinol Metab. 2022; 26(4):319-327.

PMID: 36185952 PMC: 9519841. DOI: 10.4103/ijem.ijem_164_22.


Early postpartum abnormal glucose metabolism subtype differs according to mid-trimester lipid profile in women with gestational diabetes mellitus.

Lai F, Li Z, Yue S, Pei L, Xiao H, Li Z Lipids Health Dis. 2021; 20(1):91.

PMID: 34429117 PMC: 8386098. DOI: 10.1186/s12944-021-01519-4.